Article Details

AstraZeneca Set to Acquire Alexion Pharmaceuticals in 2021

Retrieved on: 2020-12-15 17:15:00

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca Set to Acquire Alexion Pharmaceuticals in 2021. View article details on hiswai:

Excerpt

One of <b>Alexion's</b> medications is Soliris (eculizumab), which is approved in the U.S. and the EU for the treatment of generalized myasthenia gravis (gMG), ...

Article found on: myastheniagravisnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up